Literature DB >> 3338559

80% of muscarinic receptors expressed by the NB-OK 1 human neuroblastoma cell line show high affinity for pirenzepine and are comparable to rat hippocampus M1 receptors.

M Waelbroeck1, J Camus, M Tastenoy, J Christophe.   

Abstract

The NB-OK 1 human neuroblastoma cell line expressed muscarinic cholinergic receptors that could be labeled with N-[3H]methylscopolamine (a nonselective antagonist). 80% of these receptors showed high affinity for pirenzepine, i.e. belonged to the M 1 subtype found in neuronal tissues. Their binding properties were identical to those of rat hippocampus M 1 receptors, and differed from those of rat pancreas and heart muscarinic receptors. The remaining (20%) muscarinic receptors showed low affinity for pirenzepine and AF-DX 116, being therefore of an M2 beta (or B) subtype, and were similar to rat pancreatic receptors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338559     DOI: 10.1016/0014-5793(88)81441-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.

Authors:  M Waelbroeck; J Camus; M Tastenoy; J Christophe
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.

Authors:  M Waelbroeck; S Lazareno; O Pfaff; T Friebe; M Tastenoy; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

3.  Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.

Authors:  J Wess; G Lambrecht; E Mutschler; M R Brann; F Dörje
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

4.  Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.

Authors:  M Waelbroeck; M Tastenoy; J Camus; J Christophe; C Strohmann; H Linoh; H Zilch; R Tacke; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

5.  Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues.

Authors:  R Feifel; M Wagner-Röder; C Strohmann; R Tacke; M Waelbroeck; J Christophe; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

6.  M1 muscarinic receptors mediate intracellular calcium release in NB-OK1 human neuroblastoma cells.

Authors:  H W Boddeke; M Buttini; M Lichtsteiner; A Enz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

7.  Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

Authors:  M Waelbroeck; J Camus; M Tastenoy; R Feifel; E Mutschler; R Tacke; C Strohmann; K Rafeiner; J F Rodrigues de Miranda; G Lambrecht
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.